Cite
HARVARD Citation
Yang, H. et al. (2019). Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers. Clinical pharmacology in drug development. 8 (2), pp. 246-259. [Online].